Compared with the healthy volunteers, the NHL patients had significantly greater PD-L1+CD3+ and PD-L1+CD3+CD4+ percentages (median = 53.0 vs. 2.7 and 20.5 vs. 0.95, respectively; p < 0.001). This evidence concerns the gene CD4 and non-Hodgkin lymphoma.